Skip to main content
Log in

Biotransformation of amitriptyline in depressive patients: Urinary excretion of seven metabolites

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The urinary excretion of amitriptyline (AMT) and seven of its metabolites was studied by mass spectrometry in 10 depressive in-patients treated to steady-state condition with oral amitriptyline. An average of 68.3% of the dose was recovered in the urine, of which 68.6% was present as conjugates. Hydroxynortriptyline and its conjugate represented 54% of the total recovery. There was marked variation in metabolite pattern between patients. The variations were not due to concomitant medication with benzodiazepines. There was no correlation between the plasma and urine concentrations of AMT and its metabolites, except for amitriptyline conjugates. Two groups of patients could be distinguished — low and high excretors, who displayed alternative routes of metabolism. The disappearance rate of AMT from plasma was determined by the metabolic clearance of AMT to its metabolites. It varied considerably between patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Amundson ME, Manthey JA (1966) Excretion of nortriptyline hydrochloride in man. I. Detection and determination of urinary nortriptyline. J Pharm Sci 55: 277–280

    Google Scholar 

  2. Åsberg M, Cronholm B, Sjöqvist F, Tuck D (1971b) Relationship between plasma level and therapeutic effect of nortriptyline. Br Med J 3: 331–334

    Google Scholar 

  3. Alexanderson B, Borgå O (1973) A quantitative study of nortriptyline and five of its metabolites in human urine after oral administration of single and multiple dose. Eur J Clin Pharmacol 5: 174–180

    Google Scholar 

  4. Bahr C von (1972) Binding and oxidation of amitriptyline and a series of its oxidized metabolites in liver microsomes from untreated and phenobarbital-treated rats. Xenobiotica 2: 293–306

    Google Scholar 

  5. Bertilsson L, Alexanderson B (1972) Stereospecific hydroxylation of nortriptyline in man in relation to interindividual differences in its steady state plasma level. Eur J Clin Pharmacol 4: 201–205

    Google Scholar 

  6. Bertilsson I, Eichelbaum M, Mellström B, Sawe J, Schulz HU, Sjöqvist F (1980) Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in man. Life Sci 27: 1673–1677

    Google Scholar 

  7. Bickel MH, Flückiger M, Baggiolini M (1967 a) Vergleichende Demethylierung von tricyclischen Psychopharmaka durch Rattenleber-Mikrosomen. Naunyn Schmiedebergs Arch Pharmacol 256: 360–366

    Google Scholar 

  8. Biggs SR, Chasseaud LF, Hawkins DR, Midgley I (1979) Determination of anitriptyline and its major basic metabolites in human urine by high-performance liquid chromatography. Drug Metab Dispos 7: 233–236

    Google Scholar 

  9. Borgå O, Garle M (1972) A gas chromatic method for the quantitative determination of nortriptyline and some of its metabolites in human plasma and urine. J Chromatogr 68: 77–88

    Google Scholar 

  10. Braithwaite RA (1976) The significance of drug interactions in the evaluation of psychottropic drugs. Br J Clin Pharmacol (Suppl) 29–34

  11. Breyer-Pfaff U, Ewert M, Wiatr R (1978) Comparative single-dose kinetics of amitriptyline and its N-oxide in a volunteer. Arzneim Forsch (Drug Res) 28 (II): 10b, 1916–1920

  12. Caddy B, Fish F, Tranter J (1976) Studies on the oxidation of Amitriptyline. Analyst 101: 244–254

    Google Scholar 

  13. Cassano BG, Sjöstrand SE, Hansson E (1965 a) Distribution of and fate of C14-amitriptyline in mice and rats. Psychopharmacologia 8: 1–11

    Google Scholar 

  14. Coppen A (1979) Amitriptyline and its demethylation-rate. Lancet 1: 49

    Google Scholar 

  15. Corona GL, Facino RM (1968) Identification and evaluation of amitriptyline and its basic metabolites in rabbit's urine. Biochem Pharmacol 17: 2045–2050

    Google Scholar 

  16. Eichelbaum M (1981) Polymorphism of drug oxidation in man: novel findings. Trends Pharmacol Sci 31–34

  17. Eichelbaum M, Spannbrucker N, Steincke B, Dengler HJ (1979) Defective N-oxidation of sparteine in man: a new pharmacogenetic defect. Eur J Clin Pharmacol 16: 183–187

    Google Scholar 

  18. Eschenhof E, Rieder J (1979) Untersuchungen über das Schicksal des Antidepressivums Amitriptylin im Organismus der Ratte und des Menschen. Arzneim Forsch 19: 957–966

    Google Scholar 

  19. Gram L (1974) Metabolism of tricyclic antidepressants. Dan Med Bull 21: 218–231

    Google Scholar 

  20. Gram LF, Overø KF, Kirk L (1974) Influence of neuroleptics and benzodiazepines on metabolism of tricyclic antidepressants in man. Am J Psychiatry 131: 863

    Google Scholar 

  21. Greenblatt DJ, Shader RI, Koch-Weser J (1975) Flurazepam hydrochloride, a benzodiazepine hypnotic. Ann Intern Med 83: 237

    Google Scholar 

  22. Gurney C, Roth M, Garside RF, Kerr TA, Shapira K (1972) Studies in the classification of affective disorders. Br J Psychiatry 121: 162–166

    Google Scholar 

  23. Hammar CG, Alexanderson B, Holmstedt B, Sjöqvist F (1971) Gas chromatography — mass spectrometry of nortriptyline in body fluids of man. Clin Pharmacol Ther 12: 496–505

    Google Scholar 

  24. Hammer W, Mårtens S, Sjöqvist F (1969) A comparative study of the metabolism of desmethylimipramine, nortriptyline, and oxyphenylbutazone in man. Clin Pharmacol Ther 10: 44–49

    Google Scholar 

  25. Hucker HB (1962) Metabolism of Amitriptyline. Pharmacologist 4: 171

    Google Scholar 

  26. Hyttel J, Christensen AV, Fjalland B (1980) Neuropharmacological properties of Amitriptyline, Nortriptyline and their metabolites. Acta Pharmacol Toxicol 47: 53–57

    Google Scholar 

  27. Knapp DR, Gaffney TE, McMahon RE, Kiplinger G (1972) Studies on human urinary and biliary metabolites of nortriptyline with stable isotope labelling. J Pharmacol Exp Ther 180: 784–790

    Google Scholar 

  28. Leenheer A de, Heyndrickx A (1971) Identification of a major metabolite or nortriptyline in human urine. J Pharm Sci 60: 1403–1405

    Google Scholar 

  29. McMahon RE, Marshall FJ, Culp HW, Miller WM (1963) The metabolism of nortriptyline N methyl 14C in rats. Biochem Pharmacol 12: 1207–1217

    Google Scholar 

  30. Mellström B, Bertilsson L, Träskman L, Rollins D, Åsberg M, Sjöqvist F (1979) Intraindividual similarity in the metabolism of Amitriptyline and chlorimipramine in depressed patients. Pharmacology 19: 282–287

    Google Scholar 

  31. Mellström B, Braithwaite R (1978) Ion pair liquid chromatography of amitriptyline and metabolites in plasma. J Chromatogr 157: 379–385

    Google Scholar 

  32. Montgomery SA, McAuley R, Rani SJ, Montgomery DB, Braithwaite RA, Dawling S (1979) Amitriptyline plasma concentration and clinical response. Br Med J 1: 230–231

    Google Scholar 

  33. Munksgaard EC (1969) Concentrations of amitriptyline and its metabolites in urine, blood and tissue in fatal amitriptyline poisoning. Acta Pharmacol (Kbh) 27: 129–134

    Google Scholar 

  34. Orme M, Breckenridge A, Brooks RV (1972) Interactions of benzodiazepines with warfarin. Br Med J 3: 611

    Google Scholar 

  35. Robinson DS, Amidon EL (1973) Interaction of benzodiazepines with warfarin. In: Garattini S, Mussini E, Randall LO (eds) The benzodiazepines. Raven Press, New York, pp 641–646

    Google Scholar 

  36. Rollins DE, Alvan G, Bertilsson L, Gillette JR, Mellström B, Sjöqvist F, Träskman L (1980) Interindividual differences in amitriptyline demethylation. Clin Pharmacol Ther 28: 121–129

    Google Scholar 

  37. Santagostino G, Facino RM, Pirillo D (1974) Urinary excretion of amitriptyline N-oxide in humans. J Pharm Sci 63: 1690–1692

    Google Scholar 

  38. Silverman G, Braithwaite R (1972) Interaction of benzodiazepines with tricyclic antidepressants. Br Med J 4: 111

    Google Scholar 

  39. Silverman G, Braithwaite RA (1973) Benzodiazepines and tricyclic antidepressant plasma levels. Br Med J 3: 18–20

    Google Scholar 

  40. Sjöqvist F (1971) A pharmacokinetic approach to the treatment of depression. Int Pharmacopsychiatry 6: 147–169

    Google Scholar 

  41. Sjöqvist F, Alexanderson B, Åsberg M, Bertilson L, Borgå O, Hamberger B, Tuck D (1971) Pharmacokinetics and biological effects of nortriptyline in man. Acta Pharmacol Toxicol 29 (Suppl 3): 255–280

    Google Scholar 

  42. Sjöqvist F, Berglund F, Borgå O, Hammer W, Andersson S, Thorstrand C (1969 b) The PH dependent excretion of monomethylated tricyclic antidepressant in dog and man. Clin Pharmacol Ther 10: 826–833

    Google Scholar 

  43. Sjöqvist F, Hammer W, Borgå O, Azarnoff DL (1969 a) Pharmacological significance of the plasma level of monomethylated tricyclic antidepressants. Excerpta Med Int Congr Ser 180: 128–136

    Google Scholar 

  44. Sjöqvist F, Hammer W, Ideström CM, Lind M, Tuck D, Åsberg M (1968) Plasma levels of monomethylated tricyclic antidepressants and side effects in man. Excertpa Med Int Congr Ser 145: 246–257

    Google Scholar 

  45. Stevenson IH, Browning M, Crooks J (1972) Changes in human drug metabolism after long term exposure to hypnotics. Br Med J 4: 322–324

    Google Scholar 

  46. Swanson OA (1975) Benzodiazepines in psychiatry. S Afr Med J 49: 1829

    Google Scholar 

  47. Tillement JP (1973) Pharmacocinétique des antidépresseurs. Thérapie 28: 249–268

    Google Scholar 

  48. Vandel S, Vandel B, Sandoz M, Allers G, Bechtel P, Volmat R (1978) Clinical response and plasma concentration of amitriptyline and its metabolite nortriptyline. Eur J Clin Pharmacol 14: 185–190

    Google Scholar 

  49. Volmat R, Bechtel P, Allers G, Vandel B, Vandel S (1971) Mesure de la concentration plasmatique et effet antidépresseur de l'amitriptyline. Thérapie 32: 309–319

    Google Scholar 

  50. Whitnack E, Knapp DR, Holmes JC, Fowler NO, Gaffney TE (1972) Demethylation of nortriptyline by the dog lung. J Pharmacol Exp Ther 181: 288–291

    Google Scholar 

  51. Ziegler VE, Fuller TA, Biggs JT (1976) Nortriptyline and 10 hydroxynortriptyline plasma concentrations. J Pharm Pharmacol 28: 849–850

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vandel, B., Sandoz, M., Vandel, S. et al. Biotransformation of amitriptyline in depressive patients: Urinary excretion of seven metabolites. Eur J Clin Pharmacol 22, 239–245 (1982). https://doi.org/10.1007/BF00545222

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00545222

Key words

Navigation